Well as I expected, lots has been happening in the diabetes tech world while I’ve been away working on the African photographic expedition. So this post is a little bit of a catch-up. Ryzodeg At the start of August the Australian PBS was updated to include Novo’s Ryzodeg insulin. Although Novo’s long-acting Tresiba is not …
Insulin is supplied in three forms of container: Vials. Usually containing 10 ml each. Pen cartridges. Usually containing 3 ml each. Novo calls these “PenFill”: that is trademarked and not appropriate for other makes. Pre-filled disposable pens. Again usually containing 3 ml each. Note that the currently-accepted spelling is “vial”. “Phial” is a very archaic …
As someone who lives with Type 1 Diabetes, I get on with regular life just with more complexity to deal with every day. But I’m not alone! To give you an overview of how widespread this condition is in Australia in 2018, I figured it was time for a recap. The numbers I’m going to show …
In April there was big news as Sanofi’s long-acting Toujeo U300 insulin was added to the Pharmaceutical Benefits Scheme (PBS) and thus became accessible to many people. It had received TGA approval some time beforehand and was available under private prescription, but the cost was significant. But at the time I failed to mention another new …
For a change I’m not going to write here about the latest insulin pumps, CGMs, and closed-loop systems. This is about insulin pens, and possible compatibility between some models that the manufacturers won’t tell you about. Before I started using an insulin pump, I used injection pens for both my short-acting (“bolus”) insulin and my …
The 1st of April meant lots of things in Australia this year: April Fools Day, Easter Sunday, the end of Daylight Saving Time in the southeastern states, with the clocks moving back an hour, and updates to the NDSS and PBS schedules. PBS – new insulin The Pharmaceutical Benefits Scheme lists the specific drugs available …